Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2022.0663
Abstract: Importance A number of case reports and small epidemiologic studies have quantified the risk of ocular adverse events associated with the use of phosphodiesterase type 5 inhibitors (PDE5Is). However, results have been conflicting, and epidemiologic…
read more here.
Keywords:
srd rvo;
ocular adverse;
risk;
rvo ion ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Current Ophthalmology"
DOI: 10.1016/j.joco.2019.05.002
Abstract: Purpose To quantify the risk of ocular adverse events with immune checkpoint inhibitors (ICIs) as reported to the Food and Drug Administration (FDA). Methods Disproportionality analysis using data from U.S. FDA's Adverse Events Reporting System…
read more here.
Keywords:
immune checkpoint;
checkpoint inhibitors;
ocular adverse;
adverse events ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Cutaneous and Ocular Toxicology"
DOI: 10.1080/15569527.2022.2052889
Abstract: Abstract Background With the ageing population, lower urinary tract symptoms are becoming more prevalent with an estimate that by 2025, 52 million adults in the USA will be affected. After lifestyle modifications fail to resolve…
read more here.
Keywords:
medication;
review;
bladder medication;
ocular adverse ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Retina"
DOI: 10.1097/iae.0000000000002451
Abstract: PURPOSE Mitogen-activates protein kinase (MAPK) inhibitors, particularly MEK inhibitors, have shifted the treatment paradigm for metastatic BRAF-mutant cutaneous melanoma; however, oncologists, ophthalmologists, and patients have noticed different toxicities of variable importance. This review aims to…
read more here.
Keywords:
mek inhibitors;
ocular adverse;
events associated;
adverse events ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Dermatologic Therapy"
DOI: 10.1111/dth.15059
Abstract: Ocular comorbidities are more frequent in patients with severe atopic dermatitis (AD) compared to general population. Dupilumab, a fully human monoclonal antibody that prevents the signaling of interleukin (IL)‐4 and IL‐13, is reported to be…
read more here.
Keywords:
events patients;
treatment;
atopic dermatitis;
ocular adverse ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "International Journal of Dermatology"
DOI: 10.1111/ijd.15524
Abstract: dupilumab between asthma and atopic dermatitis patients Dear Editor, Dupilumab is a monoclonal antibody that inhibits the signaling of both IL-4 and IL-13, which are involved in many allergic disorders. Dupilumab is currently approved by…
read more here.
Keywords:
patients treated;
atopic dermatitis;
ocular adverse;
adverse events ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2021 at "Australian Prescriber"
DOI: 10.18773/austprescr.2021.028
Abstract: SUMMARY Some commonly prescribed drugs have ocular adverse effects. Many parts of the eye can be affected by oral drugs. Some ocular adverse effects may be reversed with medical or surgical intervention whereas other drugs…
read more here.
Keywords:
drugs ocular;
oral drugs;
ocular adverse;
effects oral ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.823346
Abstract: The vaccine is still the best clinical measure for effective prevention and control of coronavirus disease 2019 (COVID-19). The vaccine-associated ocular adverse reactions should be noted in detail among the medical community. We reported twelve…
read more here.
Keywords:
inactivated covid;
adverse reactions;
ocular adverse;
covid vaccine ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.991862
Abstract: COPYRIGHT © 2022 Kameda, Kaneko, Sugai, Ishinabe and Fukuoka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is…
read more here.
Keywords:
report associated;
adverse reactions;
commentary case;
ocular adverse ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1017889
Abstract: Background: The purpose of this study is to identify and characterize ocular adverse events (AEs) that are significantly associated with anti-VEGF drugs for treatment of neovascular age-related macular degeneration and compare the differences between each…
read more here.
Keywords:
associated anti;
ror;
vegf;
anti vegf ... See more keywords